Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

CDRH’s Shuren Signals More Guidance, Enhanced Pre-Market Payer Role

Aug 22 2013

Related Content

New Metrics For Clinical Trial Oversight Floated By CDRH Entrepreneurs In Residence

May 20 2013

The Pre-Decisional IDE: FDA’s New Proposal To Help Studies Get Started Right

Jun 17 2013

CDRH Launches ‘Innovation Pathway 2.0’ With End-Stage Renal Devices

Apr 16 2012

FDA’s Final Risk-Benefit Guidance Excludes 510(k)s, Adds De Novo Petitions

Apr 02 2012

Artificial Pancreas Guidance Allows For More Flexibility In Trial Design

Nov 19 2012

CDRH Entrepreneurs Take Two: Streamlining Data Collection And The Path To Reimbursement

Oct 22 2012

FDA-CMS Parallel Review Saves Time, Clinical Trial Costs, Participant Says

Apr 01 2013

Additional Topics

Regulation Medical Device

More from Regulation

More from Policy & Regulation

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window